Growing demand for precision medicine and biomarkers will drive C-reactive protein testing market growth.Wilmington, Delaware, United States, Feb. 15, 2024 (GLOBE NEWSWIRE) Transparency Market Research Inc. - The C-reactive protein testing market was worth US$ 3.1 billion in 2022. A CAGR of 2.9% is projected from 2023 to 2031, and the market will reach more than US$ 4.0 billion in 2031. Integrating data from diverse sources, such as genetic information, electronic health records, and real-tim
Global Efforts Intensify To Address Surging Young Adult Colorectal And Anal Cancer Rates menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Oncolytics Biotech Inc. (TSE:ONC – Get Free Report) shares reached a new 52-week low during trading on Wednesday . The stock traded as low as C$1.26 and last traded at C$1.27, with a volume of 277752 shares traded. The stock had previously closed at C$1.41. Wall Street Analysts Forecast Growth Separately, Cantor Fitzgerald restated an […]
How Recent Biotech Breakthroughs Are Changing The Fight Against Breast Cancer menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Oncolytics Biotech Inc. (TSE:ONC – Get Free Report) reached a new 52-week low during trading on Wednesday . The company traded as low as C$1.26 and last traded at C$1.27, with a volume of 277752 shares changing hands. The stock had previously closed at C$1.41. Analyst Ratings Changes Separately, Cantor Fitzgerald reissued an “overweight” rating […]